menu
    • menu

    Find Ziprasidone Hydrochloride manufacturers, exporters & distributors on PharmaCompass

    Chemwerth Ziprasidone Hydrochloride

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    33

    API Suppliers

    API Suppliers

    21

    USDMF

    US DMFs Filed

    7

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    10

    EU WC

    EU WC

    1

    KDMF

    KDMF

    9

    NDC API

    NDC API

    0

    VMF

    NDC API

    19

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 1,817

    MARKET PLACE

    4

    API

    1

    FDF

    38INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    156

    FDF Dossiers

    FDF Dossiers

    41

    FDA Orange Book

    FDA (Orange Book)

    86

    Europe

    Europe

    8

    Canada

    Canada

    12

    Australia

    Australia

    9

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    3

    EDQM

    5

    USP

    0

    JP

    7

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    4

    US Exclusivities

    16

    Health Canada Patents

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    6

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    72,326,233

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    208 RELATED EXCIPIENT COMPANIES

    347EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 122883-93-6, Ziprasidone hcl, Geodon, Zeldox, 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride, Ziprasidone (hydrochloride)
    Molecular Formula
    C21H22Cl2N4OS
    Molecular Weight
    449.4  g/mol
    InChI Key
    NZDBKBRIBJLNNT-UHFFFAOYSA-N
    FDA UNII
    JAL53626GG
    Ziprasidone Hydrochloride
    Ziprasidone Hydrochloride is the hydrochloride salt form of ziprasidone, a benzothiazolylpiperazine derivative and an atypical antipsychotic agent with an antischizophrenic property. Ziprasidone hydrochloride functions as an antagonist at the dopamine D2 and serotonin 5-HT2A and 5-HT1D receptors, and as an agonist at the 5-HT1A receptor. Ziprasidone hydrochloride also inhibits synaptic reuptake of serotonin and norepinephrine. The mechanism of action by which ziprasidone hydrochloride exerts its antischizophrenic effect is unknown but is potentially mediated through a combination of dopamine D2 and serotonin 5-HT2 antagonism. This agent also has antagonistic activity against histamine H1 and alpha-1-adrenergic receptors.
    1 2D Structure

    Ziprasidone Hydrochloride

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrochloride
    2.1.2 InChI
    InChI=1S/C21H21ClN4OS.ClH/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;/h1-4,11,13H,5-10,12H2,(H,23,27);1H
    2.1.3 InChI Key
    NZDBKBRIBJLNNT-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.Cl
    2.2 Other Identifiers
    2.2.1 UNII
    JAL53626GG
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one

    2. Cp 88059

    3. Cp 88059-01

    4. Cp-88,059

    5. Cp-88,059-01

    6. Cp-88,059-1

    7. Geodon

    8. Ziprasidone

    9. Ziprasidone Hydrochloride, Monohydrate

    10. Ziprazidone

    2.3.2 Depositor-Supplied Synonyms

    1. 122883-93-6

    2. Ziprasidone Hcl

    3. Geodon

    4. Zeldox

    5. 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one Hydrochloride

    6. Ziprasidone (hydrochloride)

    7. 5-[2-[4-(1,2-benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one Hydrochloride

    8. Ziprasidone Hydrochloride [usan]

    9. Jal53626gg

    10. 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one Hydrochloride

    11. 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one Hydrochloride

    12. Cp 88059 (hydrochloride Monohydrate)

    13. 122883-93-6 (hcl)

    14. 2h-indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, Monohydrochloride

    15. 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1h-indol-2-one Hydrochloride

    16. Cp 88059

    17. Ziprasidone Hydrochloride Hydrate

    18. C21h21cln4os.hcl

    19. Unii-jal53626gg

    20. Ziprasidone, Hcl

    21. 2h-indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, Hydrochloride (1:1)

    22. 2h-indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, Hydrochloride (1:1)

    23. Cp-88059 Hydrochloride

    24. Chembl1712

    25. Mls006010221

    26. Schembl122876

    27. Dtxsid00153762

    28. Hy-14542a

    29. S1444

    30. Akos015848366

    31. Ac-7053

    32. Ccg-220561

    33. Cs-1887

    34. Ks-1219

    35. 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrochloride

    36. Ac-26998

    37. Smr002204092

    38. Ziprasidone Hydrochloride Anhydrous

    39. Sw199027-2

    40. Z0032

    41. Ziprasidone Hydrochloride Anhydrous [mi]

    42. 939z277

    43. A890906

    44. Sr-01000759387

    45. Sr-01000759387-2

    46. Ziprasidone Hydrochloride Anhydrous [who-dd]

    47. Q27281411

    48. 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one Hcl

    49. 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone Monohydrochloride

    50. 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)-ethyl)-6-chloroindolin-2-one Hydrochloride

    51. 5-[2-[4-(1,2-benzisothiazol-3-yl)-1 -piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol- 2-one Hydrochloride

    52. 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1, 3-dihydro-2h-indol-2-one Hydrochloride

    53. Ziprasidone Hydrochloride Solution, 1.0 Mg/ml In Methanol, Certified Reference Material, Ampule Of 1 Ml

    2.4 Create Date
    2005-08-09
    3 Chemical and Physical Properties
    Molecular Weight 449.4 g/mol
    Molecular Formula C21H22Cl2N4OS
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count4
    Exact Mass448.0891379 g/mol
    Monoisotopic Mass448.0891379 g/mol
    Topological Polar Surface Area76.7 Ų
    Heavy Atom Count29
    Formal Charge0
    Complexity573
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameZiprasidone hydrochloride
    Drug LabelGEODON is available as capsules (ziprasidone hydrochloride) for oral administration and as an injection (ziprasidone mesylate) for intramuscular use only. Ziprasidone is a psychotropic agent that is chemically unrelated to phenothiazine or butyrophen...
    Active IngredientZiprasidone hydrochloride
    Dosage FormCapsule
    RouteOral
    Strengtheq 20mg base; eq 40mg base; eq 80mg base; eq 60mg base
    Market StatusPrescription
    CompanyMylan Pharms; Wockhardt; Apotex; Lupin Pharms; Sandoz; Dr Reddys Labs

    2 of 2  
    Drug NameZiprasidone hydrochloride
    Drug LabelGEODON is available as capsules (ziprasidone hydrochloride) for oral administration and as an injection (ziprasidone mesylate) for intramuscular use only. Ziprasidone is a psychotropic agent that is chemically unrelated to phenothiazine or butyrophen...
    Active IngredientZiprasidone hydrochloride
    Dosage FormCapsule
    RouteOral
    Strengtheq 20mg base; eq 40mg base; eq 80mg base; eq 60mg base
    Market StatusPrescription
    CompanyMylan Pharms; Wockhardt; Apotex; Lupin Pharms; Sandoz; Dr Reddys Labs

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Antipsychotic Agents

    Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)

    Serotonin Antagonists

    Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)

    Dopamine Antagonists

    Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)

    5.2 FDA Pharmacological Classification
    5.2.1 Pharmacological Classes
    Atypical Antipsychotic [EPC]

    API SUPPLIERS

    read-more
    read-more

    01

    ChemWerth Inc

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Booth #12.1F43
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Chemwerth Compnay Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    LGM Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Dr. Reddy's Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 17922

    Submission : 2004-12-23

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-09-30

    Valid Till : 2025-11-30

    Written Confirmation Number : WC-390A4

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 55111-801

    Start Marketing Date : 2004-12-23

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Jai Radhe Sales

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Jai Radhe Sales

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    HRV Global Life Sciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPHI Middle east
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU, MX, ... arrow-down
    ✖
    Available Reg Filing : AU, MX, ASMF
    AUDIT
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Dr. Reddy's Laboratories

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21147

    Submission : 2007-12-17

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-06

    Valid Till : 2025-07-07

    Written Confirmation Number : WC-0039

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 55111-801

    Start Marketing Date : 2004-12-23

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT
    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Wockhardt

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Wockhardt

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19503

    Submission : 2006-05-30

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Raks Pharma

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Raks Pharma

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-02-27

    Pay. Date : 2016-12-27

    DMF Number : 31183

    Submission : 2016-12-28

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    RANBAXY LABORATORIES LIMITED

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    RANBAXY LABORATORIES LIMITED

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 18042

    Submission : 2005-01-31

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Qilu Tianhe Pharmaceutical Co., Lt...

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Medlab Asia & Asia Health
    Not Confirmed
    arrow

    Qilu Tianhe Pharmaceutical Co., Lt...

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Medlab Asia & Asia Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 24837

    Submission : 2011-03-31

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Dr Reddys Laboratories Ltd

    India
    arrow
    AES 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21147

    Submission : 2007-12-17

    Status : Active

    Type : II

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Dr Reddys Laboratories Ltd

    India
    arrow
    AES 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 17922

    Submission : 2004-12-23

    Status : Active

    Type : II

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Teva Pharmaceuticals Industries Ltd

    Israel
    arrow
    CPhI WW Frankfurt
    Booth #6.1A32
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothTAPI offers customized CDMO Solutions for API development and manufacturing services.

    Contact Supplier Contact Supplier
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19005

    Submission : 2005-12-07

    Status : Inactive

    Type : II

    TAPI Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Amino Chemicals Ltd

    Malta

    USDMF

    arrow
    AES 2024
    Not Confirmed

    04

    Amino Chemicals Ltd

    Malta
    arrow
    AES 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 20105

    Submission : 2006-12-27

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Apotex Pharmachem Inc

    Canada

    USDMF

    arrow
    AES 2024
    Not Confirmed

    05

    Apotex Pharmachem Inc

    Canada
    arrow
    AES 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 18050

    Submission : 2005-02-03

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    AES 2024
    Not Confirmed

    06

    Apitoria Pharma Private Ltd

    India
    arrow
    AES 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21012

    Submission : 2007-10-29

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Lupin Ltd

    India

    USDMF

    arrow
    AES 2024
    Not Confirmed

    07

    Lupin Ltd

    India
    arrow
    AES 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 18055

    Submission : 2005-02-04

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    AES 2024
    Not Confirmed

    08

    Ranbaxy Laboratories Ltd

    India
    arrow
    AES 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 18042

    Submission : 2005-01-31

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Wockhardt Ltd

    India

    USDMF

    arrow
    AES 2024
    Not Confirmed

    09

    Wockhardt Ltd

    India
    arrow
    AES 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19503

    Submission : 2006-05-30

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    AES 2024
    Not Confirmed

    10

    Zydus Lifesciences Ltd

    India
    arrow
    AES 2024
    Not Confirmed

    GDUFA

    DMF Review : Complete

    Rev. Date : 2014-07-07

    Pay. Date : 2014-04-04

    DMF Number : 20769

    Submission : 2007-08-10

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696357800,"product":"PHARMACEUTICAL RAW MATERIAL - ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP (COMMERCIAL INVOICE NO:APL\/016\/23-24 & DATE :","address":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY","city":"HYDERABAD","supplier":"ALMELO","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"TO THE ORDER OF....","customerCountry":"PAKISTAN","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"740","totalValueFC":"3568.5","currency":"USD","unitRateINR":59400,"date":"04-Oct-2023","totalValueINR":"297000","totalValueInUsd":"3568.5","indian_port":"Hyderabad Air","hs_no":"29342000","bill_no":"4391981","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703701800,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP PHARMACEUTICAL RAW MATERIAL(COMMERCIALINVOICE NO:APL\/026\/23-24&DT:20.12.2023)","address":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY","city":"HYDERABAD","supplier":"ALMELO","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"TO THE ORDER OF....","customerCountry":"PAKISTAN","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"740","totalValueFC":"3579.9","currency":"USD","unitRateINR":59600,"date":"28-Dec-2023","totalValueINR":"298000","totalValueInUsd":"3579.9","indian_port":"Hyderabad Air","hs_no":"29342000","bill_no":"6367919","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715711400,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE-USP (PHARMACEUTICAL RAW MATERIAL) (COMMERCIAL INV NO:APL\/007\/24-25 & DT:04.05.24)","address":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY","city":"HYDERABAD","supplier":"ALMELO","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"TO THE ORDER OF....","customerCountry":"PAKISTAN","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"745","totalValueFC":"3391.4","currency":"USD","unitRateINR":56537,"date":"15-May-2024","totalValueINR":"282685","totalValueInUsd":"3391.4","indian_port":"Hyderabad Air","hs_no":"29342000","bill_no":"9890352","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725215400,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE","address":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower","city":"Hyderabad","supplier":"APITORIA PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"U.S. PHARMACOPEIA","customerCountry":"UNITED STATES","quantity":"0.37","actualQuantity":"0.37","unit":"KGS","unitRateFc":"40540","totalValueFC":"14707.5","currency":"USD","unitRateINR":3331098.8648648653,"date":"02-Sep-2024","totalValueINR":"1232506.58","totalValueInUsd":"14707.5","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"3679598","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"Floor No.22, Plot No.1, Survey No.83\/1, Galaxy Tower, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727375400,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE EP","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"ZYDUS LIFESCIENCES LIMITED","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"STADA ARZNEIMITTEL","customerCountry":"GERMANY","quantity":"58.56","actualQuantity":"58.56","unit":"KGS","unitRateFc":"1700","totalValueFC":"107423","currency":"EUR","unitRateINR":153725.70321038249,"date":"27-Sep-2024","totalValueINR":"9002177.18","totalValueInUsd":"107423","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"4371312","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727634600,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE","address":"FLAT NO 101.MATHRUSRI HOMES","city":"HYDERABAD.AP","supplier":"CHROMO LABORATORIES","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"LLC VELPHARM","customerCountry":"RUSSIA","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"83484","totalValueFC":"5868.4","currency":"INR","unitRateINR":81963.128333333341,"date":"30-Sep-2024","totalValueINR":"491778.77","totalValueInUsd":"5868.4","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"4456632","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"FLAT NO 101.MATHRUSRI HOMES, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729881000,"product":"ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP(COMMERCIAL INVOICE NO:APL\/033\/24-25 DATE:21.10.2024)","address":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY","city":"HYDERABAD","supplier":"ALMELO","supplierCountry":"INDIA","foreign_port":"ISLAMABAD - ISLAMABA","customer":"BANK ALFALAH LIMITED ","customerCountry":"PAKISTAN","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"630","totalValueFC":"2715.9","currency":"USD","unitRateINR":45641,"date":"26-Oct-2024","totalValueINR":"228205","totalValueInUsd":"2715.9","indian_port":"Hyderabad Air","hs_no":"29342000","bill_no":"5175811","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT.NO.A-39 & B-11, ROAD.NO.7, IDA KUKATPALLY, HYDERABAD","customerAddress":""}]
    04-Oct-2023
    26-Oct-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - CAPSULE;ORAL - EQ 20MG BASE

    USFDA APPLICATION NUMBER - 20825

    read-more

    DOSAGE - CAPSULE;ORAL - EQ 40MG BASE

    USFDA APPLICATION NUMBER - 20825

    read-more

    DOSAGE - CAPSULE;ORAL - EQ 60MG BASE

    USFDA APPLICATION NUMBER - 20825

    read-more

    DOSAGE - CAPSULE;ORAL - EQ 80MG BASE

    USFDA APPLICATION NUMBER - 20825

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Granulation

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Topical

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Dry Powder Inhalation

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    US Exclusivities

    read-more
    read-more

    VIATRIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ZIPRASIDONE HYDROCHLORIDE

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    M-232
    2025-01-28
    20825
    1
    blank

    01

    VIATRIS

    ZIPRASIDONE HYDROCHLORIDE

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    VIATRIS

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    ZIPRASIDONE HYDROCHLORIDE

    Exclusivity Code : M-232

    Exclusivity Expiration Date : 2025-01-28

    Application Number : 20825

    Product Number : 1

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    VIATRIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ZIPRASIDONE HYDROCHLORIDE

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    M-232
    2025-01-28
    20825
    2
    blank

    02

    VIATRIS

    ZIPRASIDONE HYDROCHLORIDE

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    VIATRIS

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    ZIPRASIDONE HYDROCHLORIDE

    Exclusivity Code : M-232

    Exclusivity Expiration Date : 2025-01-28

    Application Number : 20825

    Product Number : 2

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    VIATRIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ZIPRASIDONE HYDROCHLORIDE

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    M-232
    2025-01-28
    20825
    3
    blank

    03

    VIATRIS

    ZIPRASIDONE HYDROCHLORIDE

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    VIATRIS

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    ZIPRASIDONE HYDROCHLORIDE

    Exclusivity Code : M-232

    Exclusivity Expiration Date : 2025-01-28

    Application Number : 20825

    Product Number : 3

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    VIATRIS

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ZIPRASIDONE HYDROCHLORIDE

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    M-232
    2025-01-28
    20825
    4
    blank

    04

    VIATRIS

    ZIPRASIDONE HYDROCHLORIDE

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    VIATRIS

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    ZIPRASIDONE HYDROCHLORIDE

    Exclusivity Code : M-232

    Exclusivity Expiration Date : 2025-01-28

    Application Number : 20825

    Product Number : 4

    Exclusivity Details :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search